Delivery of NADPH-cytochrome P450 reductase antisense oligos using avidin-biotin approach

Bioconjugate Chemistry

Volumn 21, Issue 2, 2010, Pages 203-207

  Pillai, Venkateswaran C ^a   Yesudas, Rekha ^a   Shaik, Imam H ^a   Thekkumkara, Thomas J ^a   Bickel, Ulrich ^a   Srivenugopal, Kalkunte S ^a   Mehvar, Reza ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COENZYMES; ELECTROPHORESIS; ENZYME ACTIVITY; GENES; OLIGONUCLEOTIDES;

% REDUCTIONS; ANTISENSE; AVIDIN-BIOTIN; CYTOCHROME P450 REDUCTASE; EPITHELIAL CELLS; IN-VIVO; INHIBITORY RESPONSE; INTRACELLULAR DELIVERY; NADPH-CYTOCHROME P450 REDUCTASE; RAT LIVERS;

GLYCOPROTEINS;

ANTISENSE OLIGONUCLEOTIDE; AVIDIN; AVIDIN BIOTINYLATED PHOSPHORODIAMIDATE MORPHOLINO OLIGONUCLEOTIDE CONJUGATE; BIOTIN; CYTOCHROME P450 REDUCTASE; REAGENT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOTINYLATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG SYNTHESIS; ENZYME INHIBITION; EPITHELIUM CELL; GENE SILENCING; MALE; NONHUMAN; RAT; REACTION ANALYSIS;

RATTUS;

EID: 77049123764     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc900449b     Document Type: Article

References (30)

1. Horecker, B. L. (1950) Triphosphopyridine nucleotide-cytochrome c reductase in liver. J. Biol. Chem. 183, 593-605.
2. Winston, G. W., Feierman, D. E., and Cederbaum, A. I. (1984) The role of iron chelates in hydroxyl radical production by rat liver microsomes, NADPH-cytochrome P-450 reductase and xanthine oxidase. Arch. Biochem. Biophys. 232, 378-390
3. Morehouse, L. A., Thomas, C. E., and Aust, S. D. (1984) Superoxide generation by NADPH-cytochrome P-450 reductase: the effect of iron chelators and the role of superoxide in microsomal lipid peroxidation. Arch. Biochem. Biophys. 232, 366-377
4. Bosterling, B., and Trudell, J. R. (1981) Spin trap evidence for production of superoxide radical anions by purified NADPHcytochrome P-450 reductase. Biochem. Biophys. Res. Commun. 98, 569-575
5. Bachur, N. R., Gordon, S. L., Gee, M. V., and Kon, H. (1979) NADPH cytochrome P-450 reductase activation of quinine anticancer agents to free radicals. Proc. Natl. Acad. Sci. U.S.A. 76, 954-957
6. Zangar, R. C., Davydov, D. R., and Verma, S. (2004) Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol. Appl. Pharmacol. 199, 316-331
7. Davydov, D. R. (2001) Microsomal monooxygenase in apoptosis: another target for cytochrome c signaling? Trends Biochem. Sci. 26, 155-160
8. Heine, T., Glatt, H., and Epe, B. (2006) Human cytochrome P450 reductase can act as a source of endogenous oxidative DNA damage and genetic instability. Free Radic. Biol. Med. 40, 801-807
9. Ram, P. A., and Waxman, D. J. (1992) Thyroid hormone stimulation of NADPH P450 reductase expression in liver and extrahepatic tissues. Regulation by multiple mechanisms. J. Biol. Chem. 267, 3294-3301
10. Liu, D., and Waxman, D. J. (2002) Post-transcriptional regulation of hepatic NADPH-cytochrome P450 reductase by thyroid hormone: independent effects on poly(A) tail length and mRNA stability. Mol. Pharmacol. 61, 1089-1096
11. Ross, A. D., Varghese, G., Oporto, B., Carmichael, F. J., and Israel, Y. (1995) Effect of propylthiouracil treatment on NADPHcytochrome P450 reductase levels, oxygen consumption and hydroxyl radical formation in liver microsomes from rats fed ethanol or acetone chronically. Biochem. Pharmacol. 49, 979-989
12. Herrera, B., Murillo, M. M., Alvarez-Barrientos, A., Beltran, J., Fernandez, M., and Fabregat, I. (2004) Source of early reactive oxygen species in the apoptosis induced by transforming growth factor-beta in fetal rat hepatocytes. Free Radic. Biol. Med. 36, 16-26.
13. Gan, L., Vonmoltke, L. L., Trepanier, L. A., Harmatz, J. S.,Greenblatt, D. J., and Court, M. H. (2009) Role of NADPH cytochrome P450 reductase and cytochrome b5/NADH b5 reductase in variability of CYP3A activity in human liver microsomes. Drug Metab. Dispos. 37, 90-96.
14. Fattal, E., and Barratt, G. (2009) Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA. Br. J. Pharmacol. .
15. Summerton, J., and Weller, D. (1997) Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev. 7, 187-195
16. Summerton, J. E. (2007) Morpholino, siRNA, and S-DNA compared: impact of structure and mechanism of action on offtarget effects and sequence specificity. Curr. Top. Med. Chem. 7, 651-660
17. Fattal, E., and Bochot, A. (2008) State of the art and perspectives for the delivery of antisense oligonucleotides and siRNA by polymeric nanocarriers. Int. J. Pharm. 364, 237-248
18. Garcia-Chaumont, C., Seksek, O., Grzybowska, J., Borowski, E., and Bolard, J. (2000) Delivery systems for antisense oligonucleotides. Pharmacol. Ther. 87, 255-277
19. Rojanasakul, Y. Y. (1996) Antisense oligonucleotide therapeutics: Drug delivery and targeting. Adv. Drug Delivery Rev. 18, 115-131.
20. White, P. J., Anastasopoulos, F., Pouton, C. W., and Boyd, B. J. (2009) Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides. Expert Rev. Mol. Med. 11, e10.
21. Pardridge, W. M., and Boado, R. J. (1991) Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein. FEBS Lett. 288, 30-32
22. Boado, R. J., and Pardridge, W. M. (1994) Complete inactivation of target mRNA by biotinylated antisense oligodeoxynucleotide- avidin conjugates. Bioconjugate Chem. 5, 406-410
23. Pardridge, W. M., Boado, R. J., and J. L., B. (1993) Drug delivery of antisense oligonucleotides or peptides to tissues in vivo using an avidin-biotin system. Drug Delivery 1, 43-50.
24. 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex. J. Controlled Release 95, 133-141
25. Green, N. M. (1990) Avidin and streptavidin. Methods Enzymol. 184, 51-67.
26. Tsao, M. S., Smith, J. D., Nelson, K. G., and Grisham, J. W. (1984) A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells. Exp. Cell. Res. 154, 38-52.
27. Krishna, S. B., Alfonso, L. F., Thekkumkara, T. J., Abbruscato, T. J., and Bhat, G. J. (2007) Angiotensin II induces phosphorylation of glucose-regulated protein-75 in WB rat liver cells. Arch. Biochem. Biophys. 457, 16-28.
28. Phillips, A. H., and Langdon, R. G. (1962) Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterisation, and kinetic studies. J. Biol. Chem. 237, 2652-2660.
29. Shiraki, H., and Guengerich, F. P. (1984) Turnover of membrane proteins: kinetics of induction and degradation of seven forms of rat liver microsomal cytochrome P-450, NADPHcytochrome P-450 reductase, and epoxide hydrolase. Arch. Biochem. Biophys. 235, 86-96.
30. Han, J. F., Wang, S. L., He, X. Y., Liu, C. Y., and Hong, J. Y. (2006) Effect of genetic variation on human cytochrome p450 reductase-mediated paraquat cytotoxicity. Toxicol. Sci. 91, 42-48